MeRT® Receives FDA Clearance for PTSD: A New Step Toward Personalized Neuromodulation
A New Milestone for Personalized Brain Stimulation Neuromodulation continues to evolve at an extraordinary pace. While repetitive transcranial magnetic stimulation (TMS) has become an established treatment for major depressive disorder, investigators have long sought ways to make brain stimulation more…
When Two Failed Antidepressants Are Not Enough: Rethinking Treatment-Resistant Depression
Are We Defining Treatment-Resistant Depression Correctly? Treatment-resistant depression (TRD) affects millions of people worldwide and represents one of the greatest challenges in modern psychiatry. Patients with TRD experience greater disability, poorer quality of life, higher healthcare utilization, and substantially increased…
A New Brain–Computer Interface for Treatment-Resistant Depression: The Next Frontier in Interventional Psychiatry?
From Neuromodulation to Neurotechnology Over the past two decades, psychiatry has witnessed remarkable advances in neuromodulation. Treatments such as transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), and deep brain stimulation (DBS) have transformed the care of…
Deep Brain Stimulation May Rewire the Brain: New Evidence of White Matter Remodeling
For years, clinicians have observed a fascinating phenomenon in patients receiving deep-brain stimulation (DBS) for treatment-resistant depression. While some changes occur rapidly, the full antidepressant benefits often emerge gradually over weeks or months. Why does this happen? A groundbreaking study…
Focused Ultrasound for Psychiatric Disorders: A New Frontier in Incisionless Neurosurgery
Can Neurosurgery Be Performed Without an Incision? For decades, the idea of psychiatric neurosurgery has been met with both hope and hesitation. While procedures targeting specific brain circuits can provide meaningful relief for individuals with severe, treatment-resistant psychiatric disorders, traditional…
New Review Highlights the Emerging Role of the Microbiota–Gut–Brain Axis in Depression
Why Do Some Patients Remain Depressed Despite Multiple Treatments? One of the greatest challenges in psychiatry is treatment-resistant depression (TRD). Although many individuals with major depressive disorder respond to antidepressants, approximately one-third continue to experience significant symptoms despite multiple treatment…
New Study Suggests Inhaled GH001 May Represent a Breakthrough for Treatment-Resistant Depression
The Search for Faster and Better Treatments Despite the availability of antidepressant medications, many individuals with major depressive disorder fail to achieve remission. For patients with treatment-resistant depression (TRD)—typically defined as inadequate response to at least two antidepressant treatments—the burden…
Understanding Depression in 2026: From Symptoms to Precision Psychiatry
Why We Still Don’t Fully Understand Depression Depression is one of the most common and disabling conditions worldwide—affecting approximately one in six individuals over a lifetime. Yet despite decades of research, it remains one of the most complex and heterogeneous…
Magnetic Seizure Therapy vs ECT: A New Era in Convulsive Treatments for Depression?
A Long-Standing Trade-Off in Psychiatry For decades, clinicians treating severe and treatment-resistant depression have faced a difficult balance: Maximize efficacy (ECT)Minimize cognitive side effects Electroconvulsive therapy (ECT) remains one of the most effective treatments in psychiatry—but concerns about memory and…
When Depression Becomes a Medical Emergency: Recognizing and Treating Acute Suicidal Depression
Not All Depression Is the Same Depression is often viewed as a chronic, gradually evolving condition. But in some cases, it presents very differently: Rapid onset Severe symptom intensity Immediate risk to life This is acute suicidal depression, a form…